How We Learned to Say NO.

Cellular signaling and NO production. Pflugers Arch (2010) 1.38

Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep (2010) 1.25

Good stress, bad stress--the delicate balance in the vasculature. Dtsch Arztebl Int (2009) 1.23

NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol (2011) 1.08

Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol (2012) 0.96

Deleterious effects of reactive metabolites. Oxid Med Cell Longev (2016) 0.93

Thymoquinone improves aging-related endothelial dysfunction in the rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.88

Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci (2015) 0.85

cGMP becomes a drug target. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.85

The endothelial saga: the past, the present, the future. Pflugers Arch (2010) 0.81

Grape-Derived Polyphenols Prevent Doxorubicin-Induced Blunted EDH-Mediated Relaxations in the Rat Mesenteric Artery: Role of ROS and Angiotensin II. Evid Based Complement Alternat Med (2013) 0.78

Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis. Oxid Med Cell Longev (2015) 0.77

Statin improves flow-mediated vasodilation in chronic kidney diseases. Int J Hypertens (2013) 0.76

Central blood pressure and chronic kidney disease. World J Nephrol (2016) 0.76

Obesity and vascular dysfunction: the fat-e of rich and poor. Br J Pharmacol (2012) 0.75

Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase. J Am Heart Assoc (2016) 0.75